Deruxtecan (GMP)

Overview

Deruxtecan (GMP) (MC-GGFG-DXD (GMP)) is Deruxtecan ( HY-13631E ) in GMP grade. GMP-grade small molecules can be used as auxiliary reagents in cell therapy. Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and a maleimide-GGFG peptide linker, used for synthesizing Trastuzumab deruxtecan ( HY-138298A ) and Patritumab deruxtecan ( HY-P99813 ).

Application

Products | Products > GMP Small Molecules | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Drug-Linker Conjugates for ADC

Product Information

• Catalog No.: HY-13631EG
• CAS No.: 1599440-13-7
• Molecular Formula: C52H56FN9O13
• Molecular Weight: 1034.05
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source